COVID-19(6) SARS-CoV-2(3) Cancer(3) COVID19(1) long-term(1) lung cancer(1) SARS-CoV-2 IgG antibody(1) coronavirus(1) Seroconversion(1) Worry(1) Oncology clinical trials(1) offspring(1) Mortality(1) Seroprevalence(1) cohort study.(1) suspensions.(1) Breast cancer(1) Telemedicine(1) hepatitis C(1) Pandemics(1) neutrophil-to-lymphocyte ratio (NLR).(1) Cancer patients(1) Melanoma(1) pandemic(1) IgG antibodies(1) survey research(1) Secondary endpoints(1) oncologic morbidity.(1) Immunotherapy(1) Iran(1)